Related Experiment Videos
Is eye movement dysfunction a biological marker for schizophrenia? A methodological review.
1Laboratory of Clinical Psychophysiology, New York Hospital-Cornell Medical Center.
Psychological Bulletin
|July 1, 1990
Summary
Eye movement dysfunction (EMD) is common in schizophrenia patients and their relatives, suggesting it may be a biological marker for the disorder. Further research is needed to clarify its role in schizophrenia
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Eye movement dysfunction (EMD) is frequently observed in individuals with schizophrenia and their first-degree relatives.
- Existing studies suggest EMD could potentially serve as a biological marker for schizophrenia.
Purpose of the Study:
- To explore the prevalence, stability, and familial transmission of EMD in psychiatric and general populations.
- To investigate the psychological correlates of EMD in relation to schizophrenia.
- To determine the significance of EMD for understanding the pathophysiology and genetics of schizophrenia.
Main Methods:
- Review of studies on EMD prevalence, stability, and familial transmission.
- Analysis of psychological correlates associated with EMD.
- Exploration of ocular motility characteristics and pursuit adequacy measures.
Main Results:
- Suggestive evidence indicates EMD may function as a biological marker for schizophrenia.
- The precise role of EMD in schizophrenia's diagnostic scope, pathophysiology, and genetics requires further investigation.
- Ongoing research aims to identify specific EMD abnormalities as potential schizophrenia biomarkers.
Conclusions:
- EMD is prevalent in schizophrenia and may indicate a biological link.
- More detailed characterization of ocular motility is crucial for understanding EMD's significance in schizophrenia.
- Identifying specific EMD abnormalities could lead to more precise biological markers for schizophrenia.